PLAB vs ICHR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PLAB

58.8
AI Score
VS
PLAB Wins

ICHR

55.8
AI Score

Investment Advisor Scores

PLAB

59score
Recommendation
BUY

ICHR

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PLAB ICHR Winner
Forward P/E 13.2626 8.7566 ICHR
PEG Ratio 2.6419 0.1251 ICHR
Revenue Growth 2.7% 37.4% ICHR
Earnings Growth 25.6% -6.1% PLAB
Tradestie Score 58.8/100 55.8/100 PLAB
Profit Margin 19.1% 0.3% PLAB
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD PLAB

Relative Price Performance (Last 90 Days)

PLAB 1M: -1.9% · 3M: -16.5% ICHR 1M: -23.8% · 3M: -48.7%

Current Technical Phase

PLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $27.83

ICHR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.3%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $36.48

Fundamentals Snapshot

Metric PLAB ICHR
Market Cap — —
Forward P/E 13.9 10.9
Trailing P/E 10.0 503.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.4%
Gross Margin 0.3% 0.2%
Operating Margin 0.2% 0.1%
EPS 2.81 0.07
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PLAB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.